22.04.2008 13:30:00
|
Connecticut IPA Selects NextGen(R) Enterprise Solutions
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary
of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of
ambulatory healthcare information systems and connectivity solutions,
today announced that Fairfield County Physician Management
Corporation/Norwalk IPA, an independent practice association in
southwestern Connecticut, in conjunction with their partner Norwalk
Hospital, has selected NextGen Healthcare’s
suite of enterprise software solutions to enhance its clients’
clinical and administrative performance. Products selected for
implementation into member practices include NextGen EMR (Electronic
Medical Records), NextGen EPM (Enterprise Practice Management) and
NextGen ICS (Image Control System). In securing this contract, NextGen
Healthcare continues its national growth in the IPA market.
With 200 members, FCPMC/Norwalk IPA currently represents more than half
of the region’s physicians in practices of all
sizes and specialties. Rollout of the NextGen technology is underway
with four pilot practices.
FCPMC/Norwalk IPA initiated a thorough search for health information
technology and selected NextGen Healthcare because of its advanced
enterprise functionality, company stability, and superior support and
training services. "We evaluated more than 20
systems,” says Anthony DeFillippo, executive
director of Fairfield County Physician Management Corporation and point
person for the Norwalk Medical Community NextGen Initiative, "and
we picked NextGen Healthcare because it is the clear industry leader.
The depth and breadth of its ‘out-of-the-box’
content means we can implement the NextGen EMR across all of our
specialties. At the same time, tools inherent to the software give us
the flexibility to customize our workflow for maximum efficiency.” "Integration of NextGen EMR, NextGen EPM and
NextGen ICS will provide opportunities for physicians to maximize
revenue, reduce operational costs and improve clinical workflow,”
DeFillippo adds.
NextGen Healthcare’s specialty-specific
content will equip physicians with a system designed for their
individual specialties – with NextGen ICS
supporting the move to a truly paperless office. Automation will also
facilitate a reduction in transcription and medical records costs, and
help to streamline workflow processes to maximize productivity. By using
NextGen Healthcare’s structured data and
built-in reporting tools in an enterprise environment, FCPMC/Norwalk IPA
anticipates increased participation in pay-for-performance initiatives.
In addition, FCPMC/Norwalk IPA, in partnership with Norwalk Hospital,
will use NextGen products as the foundation for a community clinical
network. Linkage to other community healthcare providers is expected to
support involvement in clinical research programs and result in enhanced
care.
"Our goal is to use technology to improve
care in our community,” says Peter Stovell,
M.D., president of FCPMC/Norwalk IPA. "We
invested significant time and effort in selecting a vendor partner that
would support our vision. We came away convinced that NextGen Healthcare
would not only help us meet, but ultimately exceed, our goals.” About NextGen Healthcare
NextGen Healthcare Information Systems, Inc. a wholly owned subsidiary
of Quality Systems, Inc. (NASDAQ: QSII), develops and markets
computer-based practice management and electronic medical records
systems for medical group practices and Healthcare Systems. For more
information about NextGen, please visit www.nextgen.com and www.qsii.com.
This news release may contain forward-looking statements within the
meaning of the federal securities laws. Statements regarding future
events, developments, the Company's future performance, as well as
management's expectations, beliefs, intentions, plans, estimates or
projections relating to the future (including, without limitation,
statements concerning revenue and net income), are forward-looking
statements within the meaning of these laws and involve a number of
risks and uncertainties. Management believes that these forward-looking
statements are reasonable and are based on reasonable assumptions and
forecasts, however, undue reliance should not be placed on such
statements that speak only as of the date hereof. Moreover, these
forward-looking statements are subject to a number of risks and
uncertainties, some of which are outlined below. As a result, actual
results may vary materially from those anticipated by the
forward-looking statements. Among the important factors that could cause
actual results to differ materially from those indicated by such
forward-looking statements are: volume and timing of systems sales and
installations; length of sales cycles and installation process; the
possibility that the products will not achieve market acceptance;
seasonal patterns of sales and customer buying behavior; the development
by competitors of new or superior technologies; the timing, cost and
success or failure of new product and service introductions, development
and product upgrade releases; undetected errors or bugs in software;
product liability; changing economic, political or regulatory influences
in the health-care industry; changes in product-pricing policies;
availability of third-party products and components; competitive
pressures including product offerings, pricing and promotional
activities; the Company's ability or inability to attract and retain
qualified personnel; possible regulation of the Company's software by
the U.S. Food and Drug Administration; uncertainties concerning
threatened, pending and new litigation against the Company including
related professional services fees; uncertainties concerning the amount
and timing of professional fees incurred by the Company generally;
changes of accounting estimates and assumptions used to prepare the
prior periods' financial statements; general economic conditions; and
the risk factors detailed from time to time in Quality Systems' periodic
reports and registration statements filed with the Securities and
Exchange Commission. A significant portion of the Company's quarterly
sales of software product licenses and computer hardware is concluded in
the last month of the fiscal quarter, generally with a concentration of
such revenues earned in the final ten business days of that month. Due
to these and other factors, the Company's revenues and operating results
are very difficult to forecast. A major portion of the Company's costs
and expenses, such as personnel and facilities, are of a fixed nature
and, accordingly, a shortfall or decline in quarterly and/or annual
revenues typically results in lower profitability or losses. As a
result, comparison of the Company's period-to-period financial
performance is not necessarily meaningful and should not be relied upon
as an indicator of future performance. The Company undertakes no
obligation to publicly update any forward-looking statements, whether as
a result of new information, future events or otherwise.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Quality Systems Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |